Can You Take Wegovy for a Short Time, or Does It Need to Be Long-Term?

You've lost some weight and you're already wondering: can I stop?

It's a question our prescribers hear often, and it's a completely reasonable one. You started Wegovy, the nausea was real, the appetite shift surprised you, and now (a few months in) you might be thinking about whether you actually need to keep going. Or perhaps you came in with a fixed event on the calendar: a wedding, a health target, a surgery date. Either way, the question of short-term use matters, and it deserves a straight answer.

Wegovy contains semaglutide, a GLP-1 receptor agonist that works by reducing appetite signals and slowing gastric emptying. It is not a drug that resets your metabolism permanently. Its effects are active while you take it. When treatment stops, those signals return to their previous state, and for most people weight gradually returns too. The STEP 1 trial data, published in the New England Journal of Medicine, showed that a year after stopping semaglutide 2.4mg, participants had regained on average about two-thirds of the weight they had lost. That is not a failure of the medicine; it reflects how appetite regulation works.

So: can you take it for a short time? Yes. Will it do as much as a longer course? Almost certainly not. Those are two different questions, and both deserve honest answers.

What NICE and the licensed guidelines say about how long to continue

The NICE appraisal of semaglutide (TA875) places a two-year maximum on NHS use specifically, this applies within a specialist weight management service and is tied to how NHS commissioning works, not to a biological ceiling on what the medicine can do. In private licensed practice, the prescriber reviews suitability at each repeat, with no arbitrary cut-off, but also with no assumption that treatment continues indefinitely regardless of response.

The SmPC guidance is also clear: if a patient has not lost at least 5% of their starting body weight after six months on the maintenance dose, continuing is unlikely to be appropriate and should be reviewed. This built-in stopping rule exists not because Wegovy stops working after six months, but because it should be doing something measurable by then.

If you are thinking about short-term use for a specific reason (a planned surgery, a pregnancy you are preparing for, a period off treatment for personal reasons) those conversations happen at a clinical review. Decisions like pausing, stopping or restarting are made between you and a prescriber. For context on what the longer view looks like, our page on whether Wegovy is something people take indefinitely covers the evidence on sustained use.

What typically happens when you stop before reaching a stable weight

Stopping Wegovy early does not erase the weight you have lost, but it does remove the biological support that helped you lose it. Hunger tends to return to its previous level, sometimes gradually, sometimes quickly. This is not a sign that something has gone wrong; it is how semaglutide's mechanism works. The medicine is actively suppressing appetite signals, so once the drug clears your system, those signals reassert themselves.

The practical implication is that people who stop early, without having embedded lasting changes to eating and activity patterns, are more likely to regain weight. This is why treatment guidelines pair Wegovy with lifestyle support rather than prescribing it in isolation. It is also why, if you are considering a deliberate short course, being realistic about what happens afterwards is part of the clinical conversation.

Some people do have a defined reason to stop: a confirmed pregnancy (Wegovy is not recommended in pregnancy), significant side effects, or a clinical reassessment that concludes the benefit no longer outweighs the risk. The full Wegovy treatment overview covers the contraindications and how dose titration is managed from the start. If you are still deciding whether to begin, the question of how long you might need to continue is worth raising at the outset rather than after several months.

What actually determines how long your treatment runs

Duration is not chosen off a menu. It emerges from a clinical review that takes into account how much weight you have lost, how well you are tolerating the medicine, what your underlying health conditions are, and what your goals look like going forward. Some people find a year of treatment gives them a meaningful, sustained shift. Others need longer. A small number stop earlier because of side effects or life changes. Wegovy takes time to reach its full effect, and expectations about short courses often underestimate that curve.

Thinking about cost is natural too. The treatment cost and what is included is shown on our treatment page, prices vary by dose, and understanding the full picture before starting can help you plan realistically rather than stopping prematurely for financial reasons. You can also read about what short-term Wegovy use actually involves in practice, or explore the clinical considerations specific to shorter courses.

At nume, every repeat order goes through a clinical review before it is approved. There is no subscription that rolls forward automatically, a real prescriber looks at your case each time. If you are unsure whether treatment is right to continue or even to start, the right next step is a consultation, not a guess. Check your eligibility and our clinical team will review your situation properly.